Advertisement

Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?

Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?

Amgen stock neared its record high Friday after the company said it's "very encouraged" with midstage test results for its obesity treatment.